Medulloblastoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) |
Sergekorjian (talk | contribs) (→Race) |
||
| Line 27: | Line 27: | ||
===Race=== | ===Race=== | ||
* There is no racial predilection to medulloblastoma<ref name="pmid2010773">{{cite journal| author=Roberts RO, Lynch CF, Jones MP, Hart MN| title=Medulloblastoma: a population-based study of 532 cases. | journal=J Neuropathol Exp Neurol | year= 1991 | volume= 50 | issue= 2 | pages= 134-44 | pmid=2010773 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2010773 }} </ref> | * There is no racial predilection to medulloblastoma.<ref name="pmid2010773">{{cite journal| author=Roberts RO, Lynch CF, Jones MP, Hart MN| title=Medulloblastoma: a population-based study of 532 cases. | journal=J Neuropathol Exp Neurol | year= 1991 | volume= 50 | issue= 2 | pages= 134-44 | pmid=2010773 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2010773 }} </ref> | ||
==References== | ==References== | ||
Revision as of 15:36, 6 October 2015
|
Medulloblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Medulloblastoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Medulloblastoma epidemiology and demographics |
|
Risk calculators and risk factors for Medulloblastoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Medulloblastoma is the second most common brain tumor among the pediatric population.[1] The overall age adjusted incidence rate of medulloblastoma is approximately 0.71 per 100,000 individuals in the United States.[2] The incidence of medulloblastoma decreases with age; the median age at diagnosis is between 5 to 7 years.[3] Males are more commonly affected with medulloblastoma than females. The male to female ratio is approximately 1.44 to 1.[2]
Epidemiology and Demographics
Prevalence
- Medulloblastoma is the second most common brain tumor among the pediatric population.[1]
- Medulloblastoma is considered a rare tumor among adults, as it comprises fewer than 2% of all brain tumors among that age group.
Incidence
- The overall age adjusted incidence rate of medulloblastoma is approximately 0.71 per 100,000 individuals in the United States.[2]
Age
- The incidence of medulloblastoma decreases with age; the median age at diagnosis is between 5 to 7 years.[3]
- The molecular subgroup of medulloblastoma has an influence on the age of presentation such as:[4]
- WNT medulloblastoma subgroup presents among older children
- SHH medulloblastoma subgroup presents among infants and adults
- Group 3 medulloblastoma presents among younger children
- Group 4 medulloblastoma presents among younger children
Gender
- The overall age adjusted incidence rate of medulloblastoma among males is approximately 0.84 per 100,000 individuals in the United States.[2]
- The overall age adjusted incidence rate of medulloblastoma among females is approximately 0.58 per 100,000 individuals in the United States.
- Males are more commonly affected with medulloblastoma than females. The male to female ratio is approximately 1.44 to 1.
Race
- There is no racial predilection to medulloblastoma.[5]
References
- ↑ 1.0 1.1 Medulloblastoma. Wikipedia(2015) https://en.wikipedia.org/wiki/Medulloblastoma Accessed on September, 28th 2015
- ↑ 2.0 2.1 2.2 2.3 McKean-Cowdin R, Razavi P, Barrington-Trimis J, Baldwin RT, Asgharzadeh S, Cockburn M; et al. (2013). "Trends in childhood brain tumor incidence, 1973-2009". J Neurooncol. 115 (2): 153–60. doi:10.1007/s11060-013-1212-5. PMC 4056769. PMID 23925828.
- ↑ 3.0 3.1 Bartlett F, Kortmann R, Saran F (2013). "Medulloblastoma". Clin Oncol (R Coll Radiol). 25 (1): 36–45. doi:10.1016/j.clon.2012.09.008. PMID 23245832.
- ↑ Leary SE, Olson JM (2012) The molecular classification of medulloblastoma: driving the next generation clinical trials. Curr Opin Pediatr 24 (1):33-9. DOI:10.1097/MOP.0b013e32834ec106 PMID: 22189395
- ↑ Roberts RO, Lynch CF, Jones MP, Hart MN (1991). "Medulloblastoma: a population-based study of 532 cases". J Neuropathol Exp Neurol. 50 (2): 134–44. PMID 2010773.